S
troke affects nearly 800 000 individuals annually in the United States. Approximately 75% of these are first-ever strokes, whereas the remaining 25% are recurrent strokes (1) . Although stroke is often viewed as a disease of the elderly, it can occur at any age. Approximately 10% of all strokes occur in individuals aged 18 to 50 years (1) . Currently, stroke is the fifth most common cause of death in the United States and is a leading cause of long-term disability (1) . While younger patients may be more physically capable of recovering from stroke than older patients, poor functional outcomes are commonplace. Approximately 44% of individuals aged 18 to 50 years experience moderate disability after stroke, requiring at least some assistance with activities of daily living (ADLs) or mobility (modified Rankin Score >2) (2) . In a group of patients with ischemic stroke who were deemed as having "mild" or "improving" deficits and, therefore, not candidates for recombinant tissue-type plasminogen activator therapy, only 28% were discharged to home, whereas 16% required admission to acute rehabilitation facilities and 11% were admitted to skilled nursing facilities (3) .
Disability from stroke can present in myriad ways, depending on the affected area of the brain or spinal cord. The most common presentations are motor weakness and sensory disturbances; speech and swallowing impairments; vision loss; higher-level cognitive difficulties, such as neglect or aphasia; and mental health or personality changes. The early management of stroke in the form of medical, surgical, or rehabilitation interventions to reduce severity and prevent further complications is essential to help prevent potentially lifelong deficits (4, 5) .
The Veterans Health Administration (VHA) of the Department of Veterans Affairs (VA) estimates that approximately 15 000 veterans are hospitalized for strokerelated diagnoses each year. In 2017, the number of new patients with stroke at the VA was 8125. The VHA Quality Enhancement Research Initiative estimated the cost associated with caring for patients with new strokes as $111 million for acute inpatient care, $75 million for postacute inpatient care, and $88 million for follow-up care for the first 6 months poststroke. Approximately 15% to 30% of stroke survivors are left with severe disability, whereas 40% experience moderate functional impairments (6) . There are over 45 acute rehabilitation units in the VHA health care system today, but many veterans who are admitted to a VA medical center after surviving a stroke will find themselves in a facility that may not offer comprehensive, integrated, and coordinated stroke rehabilitation.
Stroke is more common in the older veteran population but does occur in active-duty, retiree, and other beneficiary populations served by the DoD. Comprehensive acute management of stroke can be delivered at military hospitals unless the patient meets criteria for transfer to the nearest certified stroke center. Currently, the DoD does not have certified stroke centers for the acute management of stroke and has limited inpatient rehabilitation beds. The DoD often partners with VA or civilian network providers when these services are needed. At some of the larger military hospitals, comprehensive outpatient stroke rehabilitation services may be available. Survivors of stroke who live outside of military medical center catchment areas can access community stroke resources through the TRICARE network. Although the acute management of stroke in veterans and service members is similar to management for their civilian counterparts, this patient population may differ due to the increased number of comorbid conditions that often occur in the VA population. In addition, veterans and service members often have access to more health care resources, including rehabilitation care services through community partnerships.
The American Heart Association/American Stroke Association (AHA/ASA) Guidelines for Adult Stroke Rehabilitation and Recovery, published in 2016, focused on acute care hospitalization through community reentry (7) . The focus of the current guideline is to provide VA and DoD primary care providers with recommendations and tools for the rehabilitation management of patients with stroke, with a focus on an interdisciplinary team approach. The guideline also provides stroke specialist providers with guidelines for evidence-based practice.
GUIDELINE DEVELOPMENT PROCESS
To develop these recommendations, the VA/DoD followed a process developed by the VA/DoD EvidenceBased Practice Working Group (EBPWG) that adheres to the standards described for trustworthy guidelines (8) . The EBPWG selected 4 guideline panel cochairs: 2 from the VA and 2 from the DoD. The cochairs, in conjunction with VA and DoD leaders, selected a multidisciplinary panel of practicing clinician stakeholders with specialists from a variety of disciplines, including physical medicine and rehabilitation, neurology, psychology, neuropsychology, nursing, social work, vocational rehabilitation, pharmacy, physical therapy, occupational therapy, case management, and speech language pathology, to develop this guideline. The VA/ DoD contracted with the Lewin Group, a third party with expertise in clinical practice guideline development, to facilitate meetings and the development of key questions (KQs) using the PICOTS (population, intervention, comparator, outcome, timing of outcomes measurement, and setting) format (Appendix Table 1 , available at Annals.org). A veteran/patient and family stakeholder focus group was conducted to assist in determining scope and informing the development of KQs. The guideline panel developed 12 KQs to guide the evidence review. As an update to the previous VA/ DoD Stroke Rehabilitation guideline published in 2010, the systematic search of the peer-reviewed literature, conducted by ECRI Institute, covered the period 1 April 2009 to 5 July 2018. The search methods and full results are detailed in the guideline (www.healthquality .va.gov); findings specific to benefits and harms of rehabilitation interventions for motor deficits and treatment of poststroke mood disorders are presented in an accompanying systematic review (SR) (9) . The entire guideline panel evaluated the body of evidence and developed the recommendations by using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) method (10 -12) .
RECOMMENDATIONS
The VA/DoD guideline was developed to complement the AHA/ASA Guidelines for Adult Stroke Rehabilitation and Recovery (7) . Whereas the AHA/ASA guideline covers acute care hospitalization through community reintegration, this guideline focuses on acute and long-term rehabilitation of the stroke patient. The guideline panel developed 2 algorithms (Figures 1  and 2 ) describing the patient flow from presentation with stroke deficits through discharge from rehabilitation. Appendix Table 2 (available at Annals.org) summarizes all 42 recommendations.
Key Area 1: Timing and Approach
A stroke can be devastating for patients and their families. The psychological and emotional impact of a stroke cannot be overstated, and patients may feel vulnerable and frustrated. Questions frequently arise regarding when the rehabilitation process should begin. Our systematic review found strong evidence that the rehabilitation process should begin as soon as the patient is medically stable (13) (14) (15) . Despite general consistency in the evidence supporting rehabilitation therapy as soon as medical stability is reached, there may be some variability in provider and patient preferences regarding this treatment. For example, while patients may want to mobilize as soon as possible, providers may be reluctant to recommend early mobilization due to medical concerns in the acute phase or the potential for falls.
There was also strong evidence that rehabilitation in the setting of an organized inpatient stroke unit (in a single physical location with a dedicated rehabilitation team) improved the likelihood of discharge to home in patients with a history of stroke (16) . Although many of the studies that we reviewed took place outside of the United States, they have several systemic and organizational components in common with medical care provided in the United States. Specifically, a multidisciplinary team that included physicians, nurses, and therapists with expertise in stroke rehabilitation provided care on these units. Of note, the exact makeup of the team varied somewhat among studies, and the optimal composition of such a team is still unknown. Outcomes from these units were consistently superior to outcomes after care on a general medical unit in terms of death, dependency, and discharge to home.
Key Area 2: Motor Therapy

Upper-and Lower-Limb Rehabilitation
A review of the evidence for motor rehabilitation poststroke revealed evidence supporting task-specific practice for improving upper-and lower-extremity motor function, gait, posture, and ADLs. Task-specific practice involves whole-task or pretask movements for an entire limb or limb segment, such as grasping, gripping, or mov-CLINICAL GUIDELINE Stroke Rehabilitation: Synopsis of 2019 VA/DoD Guideline ing along a trajectory to facilitate an ADL. These movements can include upper-and lower-limb movements, sitting and standing, reaching and balance activities, transfers, and functional mobility (stairs, household ambulation). The approach typically includes application of motor learning principles regarding feedback, practice schedules, task variation, and challenge of activity (17) . These interventions had various labels across publications: "task-specific practice," "task-oriented practice," and "repetitive task practice," but appeared to have similar intervention structure in that the task or a part or segment of the task was repeated multiple times during the single therapy session.
There is also evidence supporting the use of cardiovascular exercise (such as walking, aquatics, and rowing) to improve walking speed poststroke. We re- ADLs = activities of daily living; AHA = American Heart Association; ASA = American Stroke Association; CBT = cognitive behavioral therapy; IADLs = instrumental activities of daily living; PM&R = physical medicine and rehabilitation; SNRI = serotonin-norepinephrine reuptake inhibitor; SSRI = selective serotonin reuptake inhibitor.
CLINICAL GUIDELINE
Stroke Rehabilitation: Synopsis of 2019 VA/DoD Guideline viewed 1 SR, incorporating 58 randomized controlled trials (RCTs), that addressed cardiovascular training (18) . The SR found a statistically significant benefit favoring cardiovascular training, specifically walking, to increase maximum walking speed after stroke. There appears to be limited harm in offering this intervention, and the benefits seem to outweigh any potential harm. The evidence was equivocal regarding the use of mirror therapy. This intervention uses a mirror that reflects movement of the nonparetic limb back to the patient, creating a visual illusion that the paretic limb is moving. The paretic limb is typically hidden by the mirror. The concept behind this therapy is that cortical activation in the lesioned hemisphere may be induced by both the perception of movement in the paretic limb and stimulation from the nonparetic limb through interhemispheric communication.
Technology-Assisted Physical Rehabilitation
Evidence suggests that providers consider body weight-supported treadmill training and rhythmic auditory cueing as adjuncts to gait training. Providers might (24, 25) . The use of robotics for stroke rehabilitation is relatively new. The quality of current evidence for its use in upper-extremity and gait rehabilitation was limited (26 -30) . Serious limitations of trials included failure to report allocation concealment and randomization procedures, reporting bias, rudimentary analysis, failure to blind outcome assessors, serious indirectness, and serious imprecision. Reported results were mixed: One half of the 36 studies addressing motor return found improvement with use of robotics compared with control, whereas only 1 of 4 studies found an improvement in ADL function compared with control. No differences between controls and robotics were reported for gait velocity or independence with ambulation (27).
Pharmacologic Treatment
The evidence supporting the use of selective serotonin reuptake inhibitors (SSRIs) to improve motor function in patients with recent stroke was mixed (9, (31) (32) (33) . One SR of 8 RCTs including 1549 patients found that treatment with SSRIs 30 days or sooner after stroke was associated with improvements in both National Institutes of Health Stroke Scale scores and the likelihood of functional independence as measured by the modified Rankin Scale compared with placebo (31). Asadollahi and colleagues (32) evaluated fluoxetine and citalopram used in the first 90 days after stroke and found that both were associated with improved motor function as measured by the Fugl-Meyer Assessment scale compared with placebo (32). Pan and coworkers (33) similarly evaluated paroxetine for 90 days after stroke and showed improved motor function compared with placebo.
The previously mentioned studies suggest that there is a benefit to motor and functional outcomes with SSRIs used after stroke, but additional high-quality evidence, published in late 2018, challenged these findings. The FOCUS Trial Collaboration studied outcomes in over 3000 patients with recent stroke. Approximately 1500 patients received fluoxetine and 1500 patients received placebo (34) . The trial, which had more than 99% follow-up, found no differences in functional outcomes, measured by the modified Rankin Scale, at 6 months. This trial also reported a neardoubling in fracture risk with fluoxetine compared with placebo.
Key Area 3: Dysphagia
Dysphagia can be a devastating and dangerous sequela of stroke. Evidence suggests that offering Shaker exercise or chin tuck against resistance in addition to conventional dysphagia therapy may improve oral pharyngeal swallowing. For patients without tracheostomy, we also suggest expiratory muscle strength training. However, evidence was insufficient to recommend for or against neuromuscular electrical stimulation, pharyngeal electrical stimulation, or tongue-to-palate resistance training. In patients who require tube feeding, we suggest percutaneous endoscopic gastrostomy over nasogastric tube for maintenance of optimal nutrition in the postacute phase of stroke.
Key Area 4: Cognitive, Speech, and Sensory Therapy
Cognitive Therapy A 2016 SR examined the effectiveness of cognitive rehabilitation to treat memory deficits after stroke (35) . Participants included inpatient and outpatient samples (or a mixture of the 2), evaluating various memory retraining techniques and compensatory strategies delivered in both individual and group formats. Initial lowto intermediate-quality evidence for improved memory performance in support of these interventions was achieved at the end of the active phase of treatment, but these benefits did not persist on follow-up examinations. Similarly, a 2014 multicenter RCT with 153 participants that evaluated the long-term effects of memory self-efficacy (a specific type of intervention focused on education, compensatory strategy use, and reduction of interference generated by emotional overlay) found no difference between groups at 12-month follow-up (36) .
Speech Therapy
Rates of spontaneous improvement of poststroke speech, language, and cognition impairments decrease with time poststroke, making early treatment of communication disorders an important step toward achieving independence and improving quality of life. Optimal intervention timing and therapy dosage are unclear. Evidence reviewed included 2 RCTs that evaluated outcomes for patients with aphasia who received structured, intensive speech and language therapeutic interventions (37, 38) . In both studies, the intensive speech and language therapy was manual-based but individualized by the therapist, with treatments focusing on lexical and semantic retrieval and pragmatic skills (the functional use of language in context, involving the combined use of verbal and nonverbal communication). Patients in both studies showed some improvement, but long-term follow-up to evaluate the durability of the outcomes was not reported.
Spatial Therapy
Unilateral spatial neglect is defined as a failure to report, respond, or orient to novel or meaningful stimuli presented to the side opposite the brain lesion. Traditional therapy for unilateral spatial neglect includes compensatory strategies directed toward the side of the deficit, including verbal cueing, visual scanning, full head turn (proprioceptive), anchoring techniques, limb activation aids, and environmental adaptations. A remedial visual type of constraint-induced (forced use) therapy, hemifield eye patching, has also been used. It typically involves patching the right half of eyeglasses CLINICAL GUIDELINE Stroke Rehabilitation: Synopsis of 2019 VA/DoD Guideline with dark, nontranslucent tape. Two RCTs (39, 40) failed to show improvement with hemifield eye patching.
Key Area 5: Mental Health Therapy
The evidence reviewed by the work group provided mixed results regarding the use of SSRIs or serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of poststroke depression. Although many studies showed a positive prophylactic effect, evidence regarding adverse effects generated caution regarding use of these medications for prevention of depression in patients with stroke. Depression is common after stroke (30% incidence rate) and is associated with increased rates of disability and mortality (41, 42) . Thus, prevention and treatment efforts are important. Three of 4 studies showed efficacy in poststroke depression prophylaxis (43, 44) , but the FOCUS trial found an increased risk for bone fractures in patients receiving fluoxetine for 6 months (34). Although these results may not extrapolate to all SSRIs, the increased risk for bone fractures may offset the benefits of prophylactic use of SSRIs to prevent poststroke depression. Of note, two thirds of patients with stroke will not develop depression; as a result, large numbers of patients would be unnecessarily treated.
There is evidence, however, to support the use of Results demonstrated that paroxetine, citalopram, and fluoxetine were effective compared with placebo in reducing symptoms of depression. There were no differences in any of the head-to-head antidepressant comparisons, which included SSRIs, SNRIs (duloxetine, venlafaxine), an norepinephrine reuptake inhibitor (reboxetine), and tricyclic antidepressants. We did not include tricyclic antidepressants in our recommendation, however, because the VA/DoD clinical practice guideline for major depressive disorder cautions against use of these drugs as first-line treatment owing to their side-effect profile.
There is also evidence to support the use of cognitive behavioral therapy (CBT) in treating depression in patients who have had a stroke. Cognitive behavioral therapy is a short-term, structured form of psychotherapy that focuses on solving current problems by teaching patients to identify, challenge, and change unhelpful thoughts and patterns of behavior. It is a collaborative approach aimed at developing and practicing problem-solving and coping skills. A 2018 metaanalysis by Wang and colleagues (46) of 23 RCTs including 1972 participants with poststroke depression demonstrated that CBT alone (compared with attention control or standard rehabilitation) or CBT in combination with an antidepressant (vs. antidepressant alone) reduced symptoms of depression and increased remission and response rates.
Despite the large positive effect of CBT noted in this SR, the quality of the included studies limits conclusions. Fourteen of the 23 included trials were rated low quality owing to lack of adequate information on randomization procedures and blinding, low compliance with the intervention, and high attrition rates. Results were heterogeneous. Twenty-one of the trials were conducted in China; 20 of these had an open-label design. Two studies, which were single-blind trials, were conducted in the United Kingdom and the Netherlands; these higher-quality studies reported no statistically significant differences between CBT and control groups. Trials included in the SR typically excluded patients with common stroke sequelae, such as aphasia and significant cognitive impairments. Because the trials had a wide range of treatment durations (3 to 40 weeks), the long-term effectiveness of CBT was not clear.
Key Area 6: Other Functions
Work has long been thought to be beneficial to the overall psychological well-being of individuals who have experienced stroke, and return to work is a frequent goal. It is also thought that there may be longterm improved cognitive status after stroke by returning to work. Unfortunately, the evidence review did not find any studies examining the effectiveness of vocational rehabilitation assessment or interventions to support return to work for individuals with stroke.
Similarly, we did not find any specific interventions or assessment protocols to expedite safe return to driving. The work group determined, however, that it is reasonable for all patients to have a clinical assessment of their physical, cognitive, and behavioral function to determine their readiness to resume driving.
SUMMARY AND OTHER GUIDELINES
In summary, the 2019 VA/DoD CPG provides recommendations and clinical algorithms for poststroke rehabilitation care delivery with focus on 6 key areas, including timing of rehabilitation treatment; motor therapy; assessment, management, and treatment of dysphagia; cognitive rehabilitation approaches, speech and sensory therapy; mental health treatment; and community reintegration. Poststroke rehabilitation requires an interdisciplinary holistic approach to the management, treatment, and rehabilitation of poststroke sequelae, with the patient and family as vital members of the team. We recommend using these guidelines as an adjunct to the AHA/ASA for Adult Stroke Rehabilitation and Recovery (7) .
